NEW YORK, April 15, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Longfin Corp. ("Longfin") (NASDAQ:LFIN) securities between December 13, 2017 and April 2, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/longfin-corp?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (i) Longfin had material weaknesses in its operations and internal controls that hindered the Company's profitability; (ii) Longfin did not meet the requirements for inclusion in Russell indices; and (iii) as a result of the foregoing, the Defendants' public statements were materially false and misleading at all relevant times.
If you suffered a loss in Longfin you have until June 4, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/longfin-corp?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]


Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
How Marco Pharma International Preserves German Homeopathic Traditions in America
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
FTC Questions Apple News Over Alleged Bias Against Conservative Media
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 



